BIND Biosciences Inc
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2013 | $9 M | No. 3 | $2 to $10 million | equity | SEC | |
| Nov 2011 | $26 M | No. 2 | $10 to $50 million | equity | SEC | |
| Jun 2010 | $12 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
BIND Biosciences Inc chose not to state its revenue in its newest notice of a funding round (Feb 2013).
SEC Form D · Feb 2013
The industry group it chose in its notices: Biotechnology.
SEC Form D · Feb 2013
That is all the official record says: BIND Biosciences Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
8 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Flagship Ventures Fund 2004 L.P. | Venture capital | not stated | not stated | Held Series A, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Flagship Ventures General Partner LLC | Venture capital | not stated | not stated | Held Series A, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Management Co. V, L.L.C. | Venture capital | not stated | not stated | Held Series A, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Partners Entrepreneurs' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Partners Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Partners Special Founders' Fund V, L.P. | Venture capital | not stated | not stated | Held Series A, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Polaris Venture Partners V, L.P. | Venture capital | not stated | not stated | Held Series A, B, C, C-1 and D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
| Rusnano | Person | not stated | not stated | Held Series D preferred stock, 10% owner (Form 3, 2013) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 21 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Andrew S. Hirsch | Executive officer | Feb 2013 |
| Daniel Koerwer | Executive officer | Feb 2013 |
| James Wright | Executive officer | Feb 2013 |
| Jeffrey Hrkach | Executive officer | Feb 2013 |
| Scott Minick | Executive officer | Feb 2013 |
| Stephen Zale | Executive officer | Feb 2013 |
| Andrea Franz | Executive officer | Nov 2011 |
| Edward Schnipper | Executive officer | Nov 2011 |
| Paul Burgess | Executive officer | Nov 2011 |
| Ed Schnipper | Executive officer | Jun 2010 |
| Jim Wright | Executive officer | Jun 2010 |
| Amir H. Nashat | Director | Feb 2013 |
| Daniel S. Lynch | Director | Feb 2013 |
| Noubar Afeyan | Director | Feb 2013 |
| Omid C. Farokhzad | Director | Feb 2013 |
| Peter Barton Hutt | Director | Feb 2013 |
| Robert Barton Langer, Jr. | Director | Feb 2013 |
| Scott Minick | Director | Feb 2013 |
| Yuriy H. Udaltsov | Director | Feb 2013 |
| Amir S Nashat | Director | Jun 2010 |
| Omid Farokhzad | Director | Jun 2010 |
| Robert S Langer | Director | Jun 2010 |